| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = $0 ) |
| | 2027 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01DA065590 | Assessing whether use of fruit flavored ENDS relates to smoking reductions in people who smoke cigarettes: A data triangulation approach to maximize internal and external validity | 000 | 1 | NIH | 10/15/2026 | $0 |
| | 2027 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 000 | 5 | NIH | 10/13/2026 | $0 |
| | 2027 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K08CA252161 | Therapeutic implication of RB1 loss in bladder cancer | 000 | 5 | NIH | 10/13/2026 | $0 |
|
| Issue Date FY: 2026 ( Subtotal = $36,348,090 ) (Continued on the next page) |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA298785 | Epigenetic aging as a driver of racial disparities in early onset prostate cancer | 000 | 3 | NIH | 9/10/2026 | $130,651 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K12CA279869 | Preparing Nurse Scientists to Lead the Future of Oncology Research | 000 | 3 | NIH | 8/25/2026 | $778,025 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA275081 | Impact of RB activation on the pancreatic cancer epigenome and tumor microenvironment | 000 | 4 | NIH | 7/3/2026 | $505,216 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01HL167232 | Targeting CD83 to reduce leukemia relapse and GVHD after allogeneichematopoietic cell transplantation | 000 | 4 | NIH | 3/26/2026 | $675,727 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA267647 | Delineating the dystopian nature of the cell cycle in cancer | 000 | 5 | NIH | 5/13/2026 | $534,959 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01MH126282 | Investigating how stress induced changes in maternal serotonin affect offspring development and stress resilience | 000 | 6 | NIH | 3/5/2026 | $429,250 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R50CA211108 | Associate-Director Flow and Image Cytometry Roswell Park ComprehensiveCancer Center | 000 | 10 | NIH | 7/10/2026 | $342,107 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA305978 | Elucidating mechanisms underlying lung cancer lineage plasticity thatfacilitate adaptation and resistance to targeted therapy | 000 | 1 | NIH | 6/5/2026 | $719,951 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA312294 | Elucidating the impacts of body composition and physical activity on anti-tumor immunity and cancer control in advanced stage high-grade serous carcinoma | 000 | 1 | NIH | 5/22/2026 | $713,312 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | U24CA305623 | Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center | 001 | 2 | NIH | 9/17/2026 | $798,998 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA240290 | Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells | 000 | 7 | NIH | 4/21/2026 | $473,358 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | F30CA294838 | Genetic and Ancestral Determinants of Pathological and Molecular Tumor Immune Phenotypes in A Multi-Ethnic Population of Breast Cancer Patients: An Evolutionary Perspective | 000 | 2 | NIH | 8/20/2026 | $55,114 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA292730 | Decipher the Molecular Mechanisms of Breast Cancer Bone Metastasis | 000 | 2 | NIH | 3/3/2026 | $689,007 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | P30CA016056 | Roswell Park Cancer Center Support Grant | 002 | 49 | NIH | 9/14/2026 | $99,990 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | P30CA016056 | Roswell Park Cancer Center Support Grant | 001 | 49 | NIH | 9/11/2026 | $0 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | P30CA016056 | Roswell Park Cancer Center Support Grant | 000 | 49 | NIH | 7/7/2026 | $4,468,904 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | F31CA306124 | Modulating costimulation in CAR T cells to enhance antitumor efficacy | 000 | 2 | NIH | 8/17/2026 | $35,666 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283547 | Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction | 000 | 3 | NIH | 2/27/2026 | $670,321 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA279440 | The Immunomodulatory Function of Cyclin E1 in Ovarian Cancer and Therapeutic Targeting | 000 | 3 | NIH | 3/19/2026 | $505,851 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA272771 | The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer | 000 | 4 | NIH | 2/27/2026 | $468,436 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01ES034250 | STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity | 000 | 5 | NIH | 1/1/2026 | $597,213 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01HD109750 | Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits | 000 | 5 | NIH | 9/3/2026 | $449,608 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | UH3CA260602 | Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting | 002 | 6 | NIH | 8/17/2026 | $645,986 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | UH3CA260602 | Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting | 001 | 6 | NIH | 7/27/2026 | $1,750,151 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283501 | MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication | 001 | 3 | NIH | 4/17/2026 | $31,622 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283501 | MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication | 000 | 3 | NIH | 4/1/2026 | $640,437 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K08CA286765 | Leveraging small molecule inhibitors to improve CD19 CAR T cell immunotherapy for KMT2A-rearranged ALL | 000 | 4 | NIH | 6/23/2026 | $196,110 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | U24CA274159 | Coordinating and Data Management Center for Acquired Resistance to Therapy Network | 000 | 5 | NIH | 9/17/2026 | $1,926,317 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA248018 | Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies | 003 | 6 | NIH | 4/28/2026 | $396,881 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA292639 | Targeting retrotransposons for improved treatment of refractory childhood cancer | 000 | 3 | NIH | 7/7/2026 | $360,011 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA292639 | Targeting retrotransposons for improved treatment of refractory childhood cancer | 001 | 3 | NIH | 7/16/2026 | $224,100 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R35GM148071 | The Genetic Basis of Human DNA Replication Timing | 000 | 4 | NIH | 3/26/2026 | $458,040 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | F30CA284763 | Understanding the role of β2AR-signaling on ILC2 differentiation/plasticity and its implications in cancer progression | 000 | 4 | NIH | 8/21/2026 | $55,114 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R50CA283761 | Development of New Technologies at Roswell Park to Further Cancer-Based Research and Treatment Through Genome Modification | 000 | 4 | NIH | 9/1/2026 | $324,868 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA282430 | Novel synthetic lethality strategy for TP53 mutant colorectal cancer | 000 | 4 | NIH | 8/7/2026 | $510,841 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01DA057228 | Assessing pharmacokinetic and pharmacodynamic variability of Δ9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine | 000 | 5 | NIH | 7/1/2026 | $635,648 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA281862 | A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors | 000 | 4 | NIH | 9/11/2026 | $755,795 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01MD016850 | Implementation of evidence-based strategies to optimize HPV vaccination in rural primary care settings | 000 | 5 | NIH | 6/9/2026 | $527,764 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA278802 | TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors | 000 | 4 | NIH | 6/18/2026 | $698,501 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA275961 | Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma | 001 | 4 | NIH | 4/16/2026 | $52,319 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA275961 | Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma | 000 | 4 | NIH | 12/17/2025 | $470,879 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA273231 | Dissecting the Mechanism of SETDB1 and its K867 Monoubiquitination in Lung Cancer Progression | 000 | 5 | NIH | 7/21/2026 | $402,190 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R50CA283805 | Director Genomics Shared Resource | 000 | 3 | NIH | 9/17/2026 | $236,003 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA267690 | Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer | 000 | 5 | NIH | 8/12/2026 | $663,819 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R03DA066757 | Using a physiologically relevant model to identify the effect of filler materials on nicotine delivery from oral nicotine pouches | 000 | 1 | NIH | 9/16/2026 | $130,125 |
|
| Loading… |
|
